# Retinal and Choroidal Structural and Microvascular Characteristics in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Optical Coherence Tomography (OCT) and OCT Angiography (OCTA) Studies

**Authors:** Abdullah Bousamri, Mohammad Al-Shehri, Mohammad Kana'an, Talal Almutairi, Faisal Alharbi, Ahmad Aburezq, Abdulaziz Bousamri

PMC · DOI: 10.7759/cureus.104504 · Cureus · 2026-03-01

## TL;DR

This study finds that women with PCOS have thicker retinal nerve fibers and thinner central macula, but no significant changes in retinal blood vessel density.

## Contribution

The study provides new insights into retinal and choroidal changes in PCOS using OCT and OCTA, highlighting the role of disease duration in choroidal thickness.

## Key findings

- Women with PCOS have significantly thicker peripapillary retinal nerve fiber layer (RNFL) compared to controls.
- Central macular thickness is slightly reduced in PCOS patients.
- Choroidal thickness increases in PCOS, but only in studies without specified disease duration.

## Abstract

Polycystic ovary syndrome (PCOS) is a complex endocrine disorder that involves metabolic, hormonal, and inflammatory changes. These changes can affect tissues with high metabolic needs and sensitive microvascular systems. Optical coherence tomography (OCT) and OCT angiography (OCTA) are non-invasive ways to assess the structure and blood vessels of the retina and choroid. However, studies on women with PCOS have shown mixed results. This systematic review and meta-analysis set out to combine and analyze the available evidence on how PCOS affects retinal structure and microvasculature. We searched PubMed, Embase, Scopus, Web of Science, Cochrane CENTRAL, and Google Scholar from inception to February 1, 2026, for observational studies comparing OCT and OCTA results in women with PCOS and healthy controls. The main outcomes were average peripapillary retinal nerve fiber layer (RNFL) thickness, central macular thickness (CMT), subfoveal choroidal thickness (SFCT), and vessel density in the superficial and deep capillary plexus (SCP, DCP). We used the Newcastle-Ottawa Scale (NOS) to check study quality and the GRADE framework to rate the certainty of the evidence. We performed random-effects meta-analyses using mean differences (MDs) and 95% confidence intervals (CIs). We included 15 observational studies with a total of 1,370 women (737 with PCOS and 633 controls), and 13 studies were used in the quantitative analysis. Women with PCOS had a higher average RNFL thickness (MD +3.75 µm; 95% CI 2.48 to 5.01; moderate-certainty evidence) and a small but significant decrease in CMT (MD −3.29 µm; 95% CI −6.46 to −0.11; moderate certainty) compared to controls. SFCT was also higher overall (MD +58.03 µm), but there was a lot of variation between studies (I² = 99%). Subgroup analysis showed that SFCT thickening was only seen in studies where disease duration was not specified, while studies with newly diagnosed PCOS patients found no significant difference. There were no significant differences in SCP or DCP vessel density (low-certainty evidence).​ PCOS is linked to consistent changes in the retina and choroid, including thicker RNFL and thinner central macula, while the density of retinal blood vessels seems unchanged. Choroidal thickening was only found in groups where the length of disease was not specified, whereas the newly diagnosed showed no change. This shows that future studies should track disease duration over time to better understand these changes.

## Linked entities

- **Diseases:** Polycystic ovary syndrome (MONDO:0008487), PCOS (MONDO:0008487)

## Full-text entities

- **Genes:** PLXNA2 (plexin A2) [NCBI Gene 5362] {aka OCT, PLXN2}, ACE (angiotensin I converting enzyme) [NCBI Gene 1636] {aka ACE1, CD143, DCP, DCP1}, UCN3 (urocortin 3) [NCBI Gene 114131] {aka SCP, SPC, UCNIII}
- **Diseases:** ischemic retinopathies (MESH:D058437), retinal pathology (MESH:D012164), glaucoma (MESH:D005901), Androgen Excess (MESH:D014770), obesity (MESH:D009765), neuronal or (MESH:D009410), macular thinning (MESH:D013851), systemic disease (MESH:D034721), SFCT (MESH:D002833), ocular diseases (MESH:D005128), metabolic disorder (MESH:D008659), reproductive dysfunction (MESH:D060737), hypertension (MESH:D006973), Polycystic Ovary Syndrome (MESH:D011085), hyperandrogenism (MESH:D017588), microvascular injury (MESH:D017566), optic neuropathy (MESH:D009901), loss (MESH:D016388), polycystic W (MESH:C538106), neurodegenerative and metabolic disorders (MESH:D019636), multi- (MESH:D015161), inflammation (MESH:D007249), axonal swelling (MESH:D004487), neuroinflammatory (MESH:D000090862), insulin resistance (MESH:D007333), CMT (MESH:D008268), diabetes mellitus (MESH:D003920), retinal hypertrophic (MESH:D012173), endothelial dysfunction (MESH:D014652), ischemic (MESH:D002545), endocrine condition (MESH:D004700), TS (MESH:D005879), vascular dilation (MESH:D002311)
- **Chemicals:** OCTA (-)
- **Species:** Meleagris gallopavo (common turkey, species) [taxon 9103], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12950350/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12950350/full.md

## References

41 references — full list in the complete paper: https://tomesphere.com/paper/PMC12950350/full.md

---
Source: https://tomesphere.com/paper/PMC12950350